PITAVASTATIN

Generic: PITAVASTATIN CALCIUM

Upsher-Smith LaboratoriesManufacturer
ORALRoute
PITAVASTATIN CALCIUMActive Substance
2017-02-03Original Approval

PITAVASTATIN is FDA application ANDA205955, sponsored by SAWAI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
MYALGIA
459 reports
2
DIARRHOEA
359 reports
3
DIZZINESS
311 reports
4
NAUSEA
306 reports
5
DYSPNOEA
305 reports
6
DECREASED APPETITE
301 reports
7
HEADACHE
301 reports
8
FATIGUE
300 reports
9
MALAISE
292 reports
10
PRURITUS
290 reports